Main problems for biotechnology development in Spain 2020
In 2020, nearly half of the surveyed biotech companies and organizations in Spain stated that time and costs were the main challenges for biotechnology development. Access to capital and regulatory requirements followed on the list, representing the main problems for biotech development to around 42.1 percent and 36 percent of interviewed companies in the European country.
